802 articles
The FDA expanded approval of teplizumab to toddlers with preclinical type 1 diabetes, potentially delaying disease onset during critical early years.
A new NCI study reveals pancreatic and lung cancers get far less research funding per death than breast and prostate cancers.
A landmark autopsy study overturns decades of assumption, revealing heart attacks cause far fewer sudden cardiac deaths than believed.
Otarmeni restores natural hearing in patients with OTOF gene mutations — and Regeneron will offer it free in the U.S.
Some Ozempic users report emotional flattening beyond food. Experts say it's rare but highlight the need for mental health support.
Northwestern researchers uncover the brain biology and lifestyle traits behind SuperAgers who defy cognitive decline into their 80s.
Lifespan.io reviews top rejuvenation research advances including voice-based aging biomarkers and a rapamycin-exercise clinical trial.
Interim data from AACR 2026 show RZ-001 combo therapy achieved up to 61.5% response rate in hard-to-treat liver cancer patients.
Serif Biomedicines aims to create a new drug class combining mRNA and gene therapy benefits, targeting rare diseases and immune reprogramming.
A 12-week Omada Health study shows coaching and strength training dramatically improve fat loss and muscle retention alongside GLP-1 drugs.
Curve Biosciences uses AI and circulating DNA to detect organ-specific disease signals earlier than standard tests, validated in 1,482 patients.
AliveCor's CE-marked Kardia 12L brings full 12-lead ECG diagnostics to any clinic, cutting test time by a third with AI guidance.
